Crossmark

Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study

Crossref DOI link: https://doi.org/10.1186/s12877-018-0829-9

Published Online: 2018-06-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Puustinen, Juha http://orcid.org/0000-0002-4033-1539
Lähteenmäki, Ritva

Nurminen, Janne

Vahlberg, Tero

Aarnio, Pertti

Partinen, Markku

Räihä, Ismo

Neuvonen, Pertti J.

Kivelä, Sirkka-Liisa
Funding

Funding for this research was provided by:

Hilkka Kauhanen Memorial Fund

Grant EVO of Satakunta Hospital District
License Information

Text and Data Mining valid from 2018-06-15
More Information

Article History

Received: 5 June 2017

Accepted: 29 May 2018

First Online: 15 June 2018

Ethics approval and consent to participate

: The Satauni study protocol was approved by the Ethics Committee of Satakunta Hospital District (2§/7/2008) and by the National Agency for Medicines of Finland (218/2008) and registered to EudraCT (2008-0006795-30). Written informed consent was received from each participant before the study began.

: Participants gave written consent that results could be published in scientific journals anonymously when individual participants cannot be identified, no data are published at an individual level, and the results are published at a group level.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.